Daily Archives: April 1, 2014

TAG scrutinizes research, policy and prices, Paul Ryan eyes foreign aid, the Global Commission on Drug Policy highlights Hepatitis, and more . . . We’re reading pieces that deserve a second look

By on .

TAGline– Treatment Action Group takes a skeptical look at research and policy in its April Fools Day-released TAGline, highlighting issues, requiring “some degree of advocacy to remedy and ensure that the jokes don’t remain on us.” Among them, publicly funded research that leads to breakthroughs at private pharmaceutical companies that leads to high priced products, […]